The drug failed to show efficacy in terms of function or survival in a Phase III study of patients with ALS
6-²H₅)phenyl]-2
EMI1 can be used for the research of mutant EGFR-associated
Antagonist potency of JNJ-18038683 is determined by the measurement of adenylate cyclase activity in HEK293 cells expressing the human or rat 5-HT7 receptor
5-a]pyridin-6-yl}amino)-9-(oxan-4-yl)-8
N, N-Didesmethyl trimebutine-d5 hydrochloride Catalog No.:M30668-C The drug failed to showProduct information CAS Number: 1286624 16 5 Molecular Weight: 400. 91 Formula: C20H26ClNO5 Chemical Name: 2 amino 2 phenyl(3,3,4,4,4 H)butyl 3,4,5 trimethoxybenzoate hydrochloride Smiles: Cl.[2H]C([2H])([2H])C([2H])([2H])C(N)(COC(=O)C1=CC(OC)=C(OC)C(=C1)OC)C1C=CC=CC=1 InChiKey: NOKRVDGVOIZAKJ PAJIIYFZSA N InChi: InChI=1S C20H25NO5. ClH c1 5 20(21,15 9 7 6 8 10 15)13 26 19(22)14 11 16(23 2)18(25 4)17(12 14)24 3; h6 12H,5,13,21H2,1 4H3; 1H i1D3,5D2;